These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14748788)

  • 1. Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value.
    Bantis A; Giannopoulos A; Gonidi M; Liossi A; Aggelonidou E; Petrakakou E; Athanassiades P; Athanassiadou P
    Cytopathology; 2004 Feb; 15(1):25-31. PubMed ID: 14748788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.
    Kallakury BV; Sheehan CE; Rhee SJ; Fisher HA; Kaufman RP; Rifkin MD; Ross JS
    Cancer; 1999 Apr; 85(7):1569-76. PubMed ID: 10193948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
    Cher ML; Chew K; Rosenau W; Carroll PR
    Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.
    Sulik M; Guzińska-Ustymowicz K
    Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
    Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
    BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of metallothioneins on imprint smears of prostate carcinoma: correlation with clinicopathologic parameters and tumor proliferative capacity.
    Athanassiadou P; Bantis A; Gonidi M; Athanassiades P; Agelonidou E; Grapsa D; Nikolopoulou P; Patsouris E
    Tumori; 2007; 93(2):189-94. PubMed ID: 17557567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.
    Kallakury BV; Ambros RA; Hayner-Buchan AM; Sheehan CE; Malfetano JH; Ross JS
    Int J Gynecol Pathol; 1998 Oct; 17(4):320-6. PubMed ID: 9785132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
    Botticelli AR; Casali AM; Botticelli L; Zaffe D
    Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Ki-67 (MIB-1) and GLUT-1 proteins in non-advanced prostatic cancer.
    Luczynska E; Gasinska A; Wilk W
    Pol J Pathol; 2012 Dec; 63(4):272-7. PubMed ID: 23359198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.
    Hepburn PJ; Glynne-Jones E; Goddard L; Gee JM; Harper ME
    Histochem J; 1995 Mar; 27(3):196-203. PubMed ID: 7797424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters.
    Harper ME; Glynne-Jones E; Goddard L; Wilson DW; Matenhelia SS; Conn IG; Peeling WB; Griffiths K
    Prostate; 1992; 20(3):243-53. PubMed ID: 1374182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.
    Zhong W; Peng J; He H; Wu D; Han Z; Bi X; Dai Q
    Clin Invest Med; 2008; 31(1):E8-E15. PubMed ID: 18312749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
    Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
    Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of the expression of proliferation-associated nucleolar antigen p120 in human colorectal tumors.
    Ueki T; Nakayama Y; Sugao Y; Kohno K; Matsuo K; Sugimoto Y; Yamada Y; Kuwano M; Tsuneyoshi M
    Hum Pathol; 1997 Jan; 28(1):74-9. PubMed ID: 9013835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
    Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
    J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
    Stapleton AM; Zbell P; Kattan MW; Yang G; Wheeler TM; Scardino PT; Thompson TC
    Cancer; 1998 Jan; 82(1):168-75. PubMed ID: 9428494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
    Haerslev T; Jacobsen GK; Zedeler K
    Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.
    Nguyen VN; Mirejovský P; Mirejovský T; Melínová L; Mandys V
    Acta Histochem; 2000 Aug; 102(3):323-38. PubMed ID: 10990069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PCNA and Ki-67 expression in locally confined renal adenocarcinoma. Relationship with various histopathologic variables and prognostic significance].
    Tejido Sánchez A; Sánchez Chapado M; Rosino Sánchez A; Passas Martínez J; Bethencourt Codes F; Ruiz Ramos P; Leiva Galvis O
    Arch Esp Urol; 2002 Apr; 55(3):257-65. PubMed ID: 12068757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.